Holocord longitudinally extensive myelitis with brainstem and cranial nerve involvement: a severe seronegative autoimmune case
Abstract
Case Presentation: A 35-year-old previously healthy woman presented in early January 2026 with subacute neurological symptoms. The condition began with autonomic dysfunction, including constipation and urinary retention, followed within days by progressive paresthesia and weakness initially affecting the lower limbs, with proximal onset and distal progression. Over approximately 10 days, symptoms ascended to involve the upper limbs, resulting in tetraparesis. She subsequently developed bulbar symptoms, including dysphagia and dysphonia, suggesting involvement of the lower brainstem. Neurological examination revealed a complete spinal cord syndrome, with a sensory level at approximately T10, severe motor impairment predominantly in the lower limbs, diffuse hyporeflexia, and impaired proprioception. Magnetic resonance imaging demonstrated extensive longitudinal involvement from the caudal brainstem (bulbomedullary region) to the conus medullaris, consistent with holocord myelitis. The lesions showed T2/FLAIR hyperintensity, areas of intrinsic T1 hyperintensity suggestive of hemorrhagic components, and mild contrast enhancement. Cerebrospinal fluid analysis revealed inflammatory changes, with elevated protein and pleocytosis. Extensive etiological workup, including infectious, autoimmune, and neoplastic investigations, was negative. Aquaporin-4 and MOG antibodies, as well as metagenomic testing, were also negative, supporting a diagnosis of severe seronegative longitudinally extensive myelitis of probable autoimmune origin. Discussion: Holocord longitudinally extensive myelitis with brainstem involvement represents a severe inflammatory disorder characterized by diffuse neuroaxis compromise and poor functional outcomes. Although commonly associated with neuromyelitis optica spectrum disorders and MOG-associated disease, a subset of cases remains seronegative, requiring comprehensive investigation. In this case, extensive workup excluded major differential diagnoses, including infectious myelitis (viral, bacterial, and mycobacterial), systemic autoimmune diseases (such as systemic lupus erythematosus and vasculitis), paraneoplastic syndromes, and neoplastic infiltration. Negative aquaporin-4 and MOG antibodies further supported a seronegative inflammatory process. The extensive distribution and rapid progression suggest a highly aggressive immune-mediated mechanism. The presence of hemorrhagic components, although uncommon, may reflect severe disruption of the blood–spinal cord barrier and is associated with worse outcomes. Final Comments: This case illustrates a severe seronegative holocord myelitis with brainstem involvement and extensive negative workup. Despite early recognition and treatment, the patient showed minimal neurological improvement, with clinical stabilization. This highlights the potential for poor recovery even with appropriate management and reinforces the importance of early diagnosis and aggressive immunotherapy in similar presentations.